Gut Microbiota and Canine Liver Disease: Hepatic Encephalopathy
Hepatic encephalopathy (HE) is a neurological disturbance associated with severe hepatic dysfunction or portal shunting. In dogs, early signs can be subtle, including altered mentation, aimless walking, reduced response to familiar cues or episodic disorientation. Australian households commonly keep dogs as indoor companions or in mixed indoor-outdoor settings, making changes in routine behaviour especially important to document during a recheck.
The relationship between gut microbiota and canine liver disease is complex. Intestinal bacteria break down urea and amino acids, contributing to ammonia production, while the healthy liver clears ammonia through the urea cycle and converts it to urea for excretion. When hepatic clearance falls, this balance changes. Ammonia reaches the brain, where astrocyte glutamine synthesis, inflammation and oxidative stress can contribute to HE.
Hills ActivBiome provides on-demand webinar recordings, expert presentations, downloadable resources and participation certificates for veterinary professionals. The associated programme draws on researchers from institutions including Harvard T.H. Chan School of Public Health, Texas A&M University and the University of Vienna, bringing microbiome science into a clinically useful discussion of diagnosis, interpretation and ongoing care.
Ammonia Metabolism and the Gut-Liver Axis
Ammonia is generated in the gut by bacterial urease and amino-acid metabolism. Some bacteria use ammonia for growth, but the net contribution from microbial fermentation can be substantial. Liver disease and portosystemic shunting reduce first-pass clearance, allowing more ammonia and other bacterial products to enter the systemic circulation. Changes in intestinal transit, colonic pH and bile acid delivery may further alter microbial metabolism.
HE is therefore more complex than elevated ammonia alone. Ammonia crosses the blood-brain barrier and is converted to glutamine within astrocytes, contributing to osmotic swelling and disrupted neurotransmission. Microbial products can also promote inflammation and oxidative stress. Blood ammonia concentration is useful when interpreted correctly, yet normal results do not completely exclude HE, and mild hyperammonaemia may occur without comparable neurological signs.
Recognising Hepatic Encephalopathy in Dogs
The presentation can range from subtle personality change to profound central nervous system dysfunction. Circling, head pressing, blindness, tremors, seizures or coma warrant urgent investigation, particularly when the dog also has known liver disease. Some Australian owners describe such changes as the dog being “not right” or “off his head”; translating that description into a timeline can help identify progression. For recurrent seizures, a related review of gut links with epilepsy provides useful differential-diagnosis context.
Diagnosis combines the neurological examination with history, blood pressure, haematology, serum biochemistry, electrolytes, coagulation testing, bile acids and appropriately collected ammonia. Imaging, abdominal paracentesis or additional laboratory tests may be needed to identify precipitating problems. Access to tertiary referral hospitals varies across Australia, so regional NSW and northern Queensland practices may need practical plans for transport, urgent transfer and overnight monitoring.
Dysbiosis, Diet and Medication Effects
Intestinal dysbiosis may be a contributor to HE, a consequence of altered liver function, or both. Cholestatic disease can change bile delivery, while diarrhoea, constipation, reduced appetite and gastrointestinal bleeding can reshape the faecal microbiota. Antibiotics and other medications introduce further variability, making it difficult to determine whether a microbial pattern is causal or simply associated with illness and treatment.
Meal timing may also influence microbial activity and diurnal fluctuations within the canine gut. Research summarised through feeding rhythms in dogs highlights why consistent feeding records can improve clinical interpretation. Australian meal patterns may include grain-based diets, mixed rations, table scraps or treats, so dietary histories should capture actual ingredients, portions and timing rather than relying on broad labels such as “dry food” or “home diet”.
Interpreting Microbiome Evidence in Practice
Commercial faecal microbiome panels can describe community-level changes, yet they do not directly measure hepatic ammonia clearance or establish a diagnosis of HE. Faecal sampling primarily reflects the distal colon and may not represent the small-intestinal mucosa, bile acids or microbial activity within the liver. Relative abundance, sample handling and sequencing methods also affect results, so findings need to be reconciled with clinical and laboratory evidence.
Breed and genetics can influence baseline community composition, as discussed in breed-specific microbiota patterns. Comparing a dog with an inappropriate reference population may overstate disease-related change. Australian clinics should follow collection and transport instructions carefully, especially during hot weather, because delays or temperature exposure can further alter sample quality. No single taxonomic finding currently replaces routine HE assessment.
Treatment, Monitoring and Client Care
Management begins by addressing precipitating factors such as dehydration, electrolyte disturbance, constipation, gastrointestinal bleeding, infection, hypoglycaemia or medication effects. Lactulose may reduce ammonia absorption by altering colonic pH and osmotically encouraging faecal output, but dose adjustments require veterinary supervision because loose diarrhoea and dehydration can develop. Antibiotics are not routinely indicated for HE alone, and both dietary protein restriction and commercial supplements should be considered individually rather than applied automatically.
Monitoring combines neurological assessment, appetite, faecal consistency, body condition, hydration and repeat bloodwork where appropriate. Australian clients benefit from clear instructions about the practical goal of soft but formed faeces, warning signs and the timing of a recheck. Veterinary nurses may coordinate follow-up, repeat samples and communication with referral centres. Structured records help clinicians determine whether treatment is controlling neurological signs, restoring intestinal stability and improving quality of life for the dog.